levoxyl Drug Patent Profile

✉ Email this page to a colleague

When do Levoxyl patents expire, and when can generic versions of Levoxyl launch?

Levoxyl is a drug marketed by King Pharms and is included in one NDA.

The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Levoxyl

A generic version of levoxyl was approved as levothyroxine sodium by MYLAN on June 5^th, 2002.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for levoxyl?
What are the global sales for levoxyl?
What is Average Wholesale Price for levoxyl?

Summary for levoxyl

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	114
Clinical Trials:	1
Patent Applications:	4,345
Drug Prices:	Drug price information for levoxyl
Drug Sales Revenues:	Drug sales revenues for levoxyl
What excipients (inactive ingredients) are in levoxyl?	levoxyl excipients list
DailyMed Link:	levoxyl at DailyMed

Drug patent expirations by year for levoxyl

Recent Clinical Trials for levoxyl

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	N/A
Children's Hospital of Philadelphia	N/A

See all levoxyl clinical trials

Pharmacology for levoxyl

Drug Class	l-Thyroxine

US Patents and Regulatory Information for levoxyl

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-001	May 25, 2001	AB1,AB3	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-007	May 25, 2001	AB1,AB3	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-004	May 25, 2001	AB1,AB3	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for levoxyl

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-006	May 25, 2001	⤷ Sign Up	⤷ Sign Up
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-005	May 25, 2001	⤷ Sign Up	⤷ Sign Up
King Pharms	LEVOXYL	levothyroxine sodium	TABLET;ORAL	021301-012	May 25, 2001	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for levoxyl

See the table below for patents covering levoxyl around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	03061557		⤷ Sign Up
European Patent Office	1474103		⤷ Sign Up
European Patent Office	1365745		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for levoxyl

Recent Clinical Trials for levoxyl

Pharmacology for levoxyl

Make Better Decisions: Try a trial or see plans & pricing